Data and Technology

Johnson & Johnson VP comments on building digital capabilities into workflows.

Expert panel identifies five key areas where patient-centric strategies can benefit supply chains the most—and lead to better patient outcomes.

Multi-enterprise information tower to facilitate exchange of interoperable commerce, inventory, logistics, and other supply chain data.

In this latest Harvard Business School Healthcare Alumni Association Q&A, Dr. Peter Cappelli, Professor of Management at The Wharton School and Director of Wharton’s Center for Human Resources, explains how biopharma C-suites can lead their teams through 2023’s turbulent times.

Joint initiative integrates submitted claims with parties’ platforms in effort to avoid duplicate data.

Innovation and investment in advancing lifesaving therapies for pediatric patients to the commercial stage remains a daunting task, but rapid advances today in modeling and simulation are reducing the hurdles for drugmakers.

How molding these elements into one can add efficiencies to work processes.

With the rapid rise of the specialty drug market, manufacturers are increasingly relying on new advances used by patient hubs to boost their levels of patient engagement.

Deciphering the different "technology-first” and “technology-enabled” patient support programs.

Why deploying AI and analytics in tandem is a key targeting tool.

Why automation-enabling tech—such as NLP and ML—can help improve medicine effectiveness.

Q&A explores new opportunities to strengthen supply chain resilience—and build on the lessons learned.

In an effort to strengthen supply chain, unnamed pharma company to use chain of custody application to combat an illegal global market worth up to $200 billion annually.

Acquisition expands company’s eCTD submission capabilities.

Site expected to support growth of advanced analytics and data science team.

Conclusion driven by various factors, including product shortages and cost pressures.

Meanwhile, PDG issues more DSCSA guidance on data interoperability.

How artificial intelligence and real-world data has not just helped predict patient behavior, but has also been successful at the point-of-care for life sciences companies.  

Platform expected to allow customers to meet various logistics requirements, company says.

Using technology to personalize customer engagement, build HCP trust.

Agreement focused on streamlining and automating manufacturing of cell and gene therapies

Dr. Liz Kwo of Everly Health outlines 2023 predictions for AI, including how it can be beneficial to patients

Action enables the company to begin offering its unit-load device for shipments

Semiannual update includes better revenue forecasting and state reporting

Observations from recent digital health events and a glimpse of what’s ahead—from Milan to Boca Raton

How taking steps to incorporate data into all regulatory and labeling operations helps firms avoid retroactively planning to recapture information

Dr. Troy Sarich of Janssen reveals the company's approach to tackling financial challenges as they pertain to tech

Featuring manufacturing technology, the new facility supports medicines supply chain resilience

Stakeholders are investing heavily in their ability to curate appropriate data sets and devise advanced data-analytics capabilities to harness real-world evidence (RWE) across the entire pharma lifecycle—from drug discovery and development through product launch and commercialization

How to make commercial AI actionable in the last mile, helping to better realize data science investment and improve customer engagement